EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploiting the Achilles’ Heel of Viral RNA Processing to Develop Novel Antivirals

Ali Zahedi Amiri iD, Choudhary Ahmed, Subha Dahal iD, Filomena Grosso, Haomin Leng, Peter Stoilov, Maria Mangos, Johanne Toutant, Lulzim Shkreta, Liliana Attisano iD, Benoit Chabot iD, Martha Brown und 2 weitere

Viruses · 2024

DOI: 10.3390/v17010054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Ali Zahedi Amiri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Virocarb Inc., Toronto, ON M8V 3Y3, Canada. Hauptthemen laut MEDLINE: Antiviral Agents, RNA, Viral, RNA Processing, Post-Transcriptional. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Virocarb Inc, Toronto COVID-19 Action Initiative, Connaught Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment options for viral infections are limited and viruses have proven adept at evolving resistance to many existing therapies, highlighting a significant vulnerability in our defenses. In response to this challenge, we explored the modulation of cellular RNA metabolic processes as an alternative paradigm to antiviral development. Previously, the small molecule 5342191 was identified as a potent inhibitor of HIV-1 replication by altering viral RNA accumulation at doses that minimally affect host gene expression. In this report, we document 5342191 as a potent inhibitor of adenovirus, coronavirus, and influenza replication. In each case, 5342191-mediated reduction in virus replication was associated with altered viral RNA accumulation and loss of viral structural protein expression. Interestingly, while resistant viruses were rapidly isolated for compounds targeting either virus-encoded proteases or polymerases, we have not yet isolated 5342191-resistant variants of coronavirus or influenza. As with HIV-1, 5342191’s inhibition of coronaviruses and influenza is mediated through the activation of specific cell signaling networks, including GPCR and/or MAPK signaling pathways that ultimately affect SR kinase expression. Together, these studies highlight the therapeutic potential of compounds that target cellular processes essential for the replication of multiple viruses. Not only do these compounds hold promise as broad-spectrum antivirals, but they also offer the potential of greater resilience in combating viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsRNA, ViralRNA Processing, Post-TranscriptionalHumansVirus ReplicationCoronavirusAnimalsAdenoviridaeHIV-1Orthomyxoviridae

Stichwörter der Autor:innen

RNA processingadenovirusbroad-spectrum antiviralcoronavirusinfluenza

Substanzen

Antiviral AgentsRNA, Viral

Autor:innen und Institutionen

  • Virocarb Inc., Toronto, ON M8V 3Y3, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV 26506, USA.
  • Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G 1X8, Canada.

ORCID-Profile: Ali Zahedi Amiri, Subha Dahal, Liliana Attisano, Benoit Chabot, Alan Cochrane

Förderung

  • Virocarb Inc
  • Toronto COVID-19 Action Initiative
  • Connaught Innovation Fund
  • CIHR
  • PRiME fellowship (Precision Medicine Initiative at the University of Toronto)

Zitieren

APA

Zahedi Amiri, A., Ahmed, C., Dahal, S., Grosso, F., Leng, H., Stoilov, P., Mangos, M., Toutant, J., Shkreta, L., Attisano, L., Chabot, B., Brown, M., Huesca, M., & Cochrane, A. (2024). Exploiting the Achilles’ Heel of Viral RNA Processing to Develop Novel Antivirals. Viruses. https://doi.org/10.3390/v17010054

Vancouver

Zahedi Amiri A, Ahmed C, Dahal S, Grosso F, Leng H, Stoilov P, et al. Exploiting the Achilles’ Heel of Viral RNA Processing to Develop Novel Antivirals. Viruses. 2024. doi:10.3390/v17010054

BibTeX
@article{ZahediAmiri2024,
  author = {Zahedi Amiri, Ali and Ahmed, Choudhary and Dahal, Subha and Grosso, Filomena and Leng, Haomin and Stoilov, Peter and Mangos, Maria and Toutant, Johanne and Shkreta, Lulzim and Attisano, Liliana and Chabot, Benoit and Brown, Martha and Huesca, Mario and Cochrane, Alan},
  title = {Exploiting the Achilles’ Heel of Viral RNA Processing to Develop Novel Antivirals},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v17010054}
}
Kostenlos starten →